Bacterial Isolates and Antibacterial Resistance Patterns in a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Tertiary Teaching Hospital, Southwest Ethiopia

Table 7

Distribution of antibiotics resistance of bacterial isolates from acute exacerbation of chronic obstructive pulmonary disease patients to different antibiotic classes at JUMC, southwest Ethiopia, 2019.

Isolates	NO	Penicillins		3rd generation cephalosporin		4th generation cephalosporin	Aminoglycoside		Phenicols	Tetracycline	Folate pathway inhibitors	Amoxicillin + Calculates	Fluoroquinolone	Cephamycins	Carbapenems	Lincosamides	Macrolides
		P	Amp	CRO	CAZ	FEP	TOB	CN	CAF	DOXY	SXT	AMC	CIP	FOX	MERR	CLD	ERY
K. pneumoniae	6	—	6	5	5	4	1	1	4	4	5	2	2	—	0	—	—
E. coli	4	—	4	3	3	3	1	1	2	3	4	3	2	—	1	—	—
Proteus spp.	3	—	3	3	3	3	1	1	2	3	3	2	3	—	1	—	—
P. aeruginosa	7	—	—	7	7	7	3	3	7	7	7	7	1	—	0	—	—
Acinetobacter spp.	4	—	—	4	4	3	2	2	3	4	4	3	2	—	1	—	—
H. influenza	1	—	—	—	0	0	—	—	0	1	0	0	1	—	0	—	—
S. aureus	5	5	—	—	—	—	1	1	3	4	3	—	2	5	—	3	4
S. pneumoniae	2	1	—	—	—	—	—	—	0	1	0	—	—	—	—	0	1

CAZ-ceftazidime, FEP-cefepime, AMC-amoxicillin-clavulanate, CRO-ceftriaxone, MRP–meropenem, CAF-chloramphenicol, AMP-ampicillin, P-penicillin, TOB-tobramycin, CN-gentamycin, CIP-ciprofloxacin, FOX-cefoxitin, SXT-trimethoprim-sulfamethoxazole, Dox-doxycycline, ERY-erythromycin, CLD-clindamycin, and spp., species.